| 08/09 | Novavax tumbles 30% as waning COVID-19 vaccine demand hits outlook | RE |
| 08/09 | European Commission, Moderna Map Out COVID-19 Vaccine Rollout for Autumn, Summer | MT |
| 08/09 | Novavax tumbles 31% as waning COVID vaccine demand hits revenue forecast | RE |
| 08/08 | Novavax sinks after halving sales forecast on low vaccine demand, supply glut | RE |
| 08/08 | GlaxoSmithKline, IQVIA Introduce Vaccination Data Tracker | MT |
| 08/08 | INSIDER SELL : Moderna | MT |
| 08/08 | INSIDER SELL : Moderna | MT |
| 08/04 | Goldman Sachs Raises Moderna's Price Target to $296 From $290, Maintains Buy Rating | MT |
| 08/04 | Morgan Stanley Adjusts Moderna's Price Target to $197 From $199, Maintains Equalweight .. | MT |
| 08/04 | Morgan Stanley Raises Alnylam Pharmaceuticals Price Target to $225 From $159, Maintains.. | MT |
| 08/04 | SVB Securities Adjusts Moderna's Price Target to $74 from $77, Keeps Underperform Ratin.. | MT |
| 08/04 | ANALYST RECOMMENDATIONS : Illinois Tool Works, Eaton, Marathon Petroleum, Microchip Techno.. | |
| 08/04 | Needham Adjusts Price Target on Alnylam Pharmaceuticals to $240 From $205, Reiterates B.. | MT |
| 08/04 | Merck KGaA profit gets boost from dollar, outweighing higher costs | RE |
| 08/04 | Moderna Reiterates $21 Billion COVID-19 Vaccine Sales Forecast On Expected New Approval.. | MT |
| 08/03 | Morgan Stanley Adjusts Price Target on Alnylam Pharmaceuticals to $225 From $159, Keeps.. | MT |
| 08/03 | Chardan Research Lifts Price Target on Alnylam Pharmaceuticals to $250 From $200 on Pat.. | MT |
| 08/03 | US Stocks Advance on Surprise Increase in Service Activity, Rise in Factory Orders | MT |
| 08/03 | Nasdaq ends at three-month high as PayPal fuels optimism | RE |
| 08/03 | Nasdaq ends at three-month high as PayPal fuels optimism | RE |
| 08/03 | SECTOR UPDATE : Health Care Stocks Hanging on for Modest Gains | MT |
| 08/03 | Nasdaq hits three-month high as PayPal fuels optimism | RE |
| 08/03 | Top Midday Gainers | MT |
| 08/03 | MIDDAY REPORT : US Stocks Rise With Treasury Yields After ISM Services Index Posts Surpris.. | MT |
| 08/03 | SECTOR UPDATE : Health Care Stocks Edging Higher This Afternoon | MT |
| 08/03 | Wall Street rises on tech, earnings boost as recession fears ease | RE |
| 08/03 | Earnings Flash (MRNA) MODERNA Posts Q2 Revenue $4.75B | MT |
| 08/03 | Moderna Up Over 16%, on Pace for Largest Percent Increase Since November 2021 -- Data T.. | DJ |
| 08/03 | Moderna Reiterates Full-Year Vaccine Sales Outlook Despite Low COVAX Orders After Secon.. | MT |
| 08/03 | Alnylam Pharmaceuticals Meets Primary Endpoint in Phase 3 Clinical Trial of Patisiran; .. | MT |
| 08/03 | US STOCKS-Strong earnings lift Wall Street ahead of services activity data | RE |
| 08/03 | SECTOR UPDATE : Health Care Stocks Advance Pre-Bell Wednesday | MT |
| 08/03 | TRANSCRIPT : Alnylam Pharmaceuticals, Inc. - Special Call | CI |
| 08/03 | TRANSCRIPT : Moderna, Inc., Q2 2022 Earnings Call, Aug 03, 2022 | CI |
| 08/03 | Stocks Signal Higher Session as US Futures Gain Pre-Bell; Asia Mostly Gains, Europe Adv.. | MT |
| 08/03 | Moderna Earnings Decline While Sales Increase in Q2; Adds $3 Billion Share Buyback | MT |
| 08/03 | Wall Street Leans Forward Pre-Bell; Futures Green, Europe Up, Asia Higher | MT |
| 08/03 | Moderna, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June.. | CI |
| 08/03 | Alnylam Reports Positive Topline Results from APOLLO-B Phase 3 Study of Patisiran in Pa.. | CI |
| 08/01 | Berenberg Bank Adjusts Seagen's Price Target to $183 From $180, Maintains Buy Rating | MT |
| 08/01 | INSIDER SELL : Moderna | MT |
| 08/01 | SVB Securities Adjusts Moderna's Price Target to $77 From $70, Maintains Underperform R.. | MT |
| 07/29 | INSIDER SELL : Moderna | MT |
| 07/29 | INSIDER SELL : Moderna | MT |
| 07/29 | IQVIA Holdings Inc. Announces Executive Changes | CI |
| 07/29 | Stifel Nicolaus Adjusts Seagen Price Target to $170 From $145, Maintains Hold Rating | MT |
| 07/29 | Morgan Stanley Lowers Alnylam Pharmaceuticals' Price Target to $159 From $164, Keeps Eq.. | MT |
| 07/29 | Morgan Stanley Raises Seagen's Price Target to $181 From $180, Maintains Overweight Rat.. | MT |
| 07/29 | Oppenheimer Adjusts Alnylam Pharmaceuticals' Price Target to $170 From $205, Maintains .. | MT |
| 07/29 | SECTOR UPDATE : Consumer Stocks Mixed Premarket Friday | MT |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
